Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
Correlation of cognitive impairment and thalamic atrophy in MS: For men only?
Where Do AQP4 Antibodies Fit in the Pathogenesis of NMO?
Effects of adjunct low-dose vitamin d on relapsing-remitting multiple sclerosis progression: preliminary findings of a randomized placebo-controlled trial.
Cognitive dysfunction in multiple sclerosis.
Dynamic Development of Glucocorticoid Resistance during Autoimmune Neuroinflammation.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group.
Control of experimental autoimmune encephalomyelitis by T cells responding to activated T cells.
Novel immunoregulatory properties of EGCG on reducing inflammation in EAE.
Validation of semaphorin 7A and ala-β-his-dipeptidase as biomarkers associated with the conversion from clinically isolated syndrome to multiple sclerosis.
Axonal Loss in a Rat Model of Optic Neuritis Is Closely Correlated with Visual Evoked Potential Amplitudes Using Electroencephalogram-based Scaling.
Response to disease modifying therapies in African Americans with multiple sclerosis.
Continuous prediction of secondary progression in the individual course of multiple sclerosis.
Increased oligodendrogenesis by humanin promotes axonal remyelination and neurological recovery in hypoxic/ischemic brains.
Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition.
Pharmacology of HIV integrase inhibitors.
PML-IRIS during Fingolimod Diagnosed after Natalizumab Discontinuation.
The gut microbiome in multiple sclerosis.
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation.
Investigation of the relationship between vitamin D and bone mineral density in newly diagnosed multiple sclerosis.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Brain imaging and bladder function.
A prospective, randomized, controlled trial of autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: a position paper.
Blockade of CD47 ameliorates autoimmune inflammation in CNS by suppressing IL-1-triggered infiltration of pathogenic Th17 cells.
Pages
« first
‹ previous
…
218
219
220
221
222
223
224
225
226
…
next ›
last »